The exhibition giant reports its fourth-quarter 2024 results, with CEO Sean Gamble saying the dividend "marks another major ...

We recently published a list of 15 Highest-Priced Stocks Right Now. In this article, we are going to take a look at where ...

Through Friday, with the latest quarterly results in from more than three-fifths of the S&P 500, 77% have turned in earnings per share higher than analysts expected, according to FactSet.

Drugmaker Incyte Corp reported fourth-quarter revenue above Wall Street estimates on Monday, boosted by strong demand for its key blood-cancer drug Jakafi and skin-disorder treatment Opzelura.

The world’s largest beauty group L’Oreal said Friday that it plans to become less dependent on the Chinese consumer for ...

Analysts offered mixed reactions following Google's earnings report, with many adjusting their price targets due to concerns over rising CapEX and slowing cloud revenue growth ...

Tata Consultancy Services has reduced variable pay of senior employees for the third quarter ended December 2024 despite them adhering to the company's work from office norms. This is the second ...

For the first time in weeks, it looks like Democrats are summoning something passing for a plan to counter the unapologetic chaos radiating from the reinstalled administration of President Donald ...

Dietary measures and medications may help reduce uric acid and manage gout. Gout can occur when blood uric acid levels are too high, causing crystals to form in the toes, feet, and other joints ...

Ahead of the event, analysts expect the Norwalk, Connecticut-based company to report a profit of $4.20 per share, down marginally from $4.22 per share in the year-ago quarter. However, the company ...